Paradigm shifts in multiple sclerosis management: Implications for daily clinical practice

Area of Science:

• Neurology
• Immunology
• Pharmacology

Background:

• Multiple sclerosis (MS) is a leading chronic inflammatory neurological condition.
• Disease-modifying therapies (DMTs) have significantly advanced MS management.
• DMTs vary in mechanism, administration, efficacy, and safety.

Purpose of the Study:

• To review current and emerging treatment strategies for MS.
• To discuss the principles and challenges of personalized medicine in MS therapy.
• To evaluate the impact of different DMT initiation strategies on patient outcomes.

Main Methods:

• Review of current literature on MS treatment paradigms.
• Analysis of real-world data on DMT efficacy and patient outcomes.
• Discussion of personalized medicine approaches in active relapsing MS (RMS).

Main Results:

• DMTs have transformed the management of MS, improving disease control and slowing disability.
• Personalized medicine seeks to optimize treatment based on individual patient factors.
• Emerging evidence suggests early initiation of high-efficacy DMTs may benefit RMS patients long-term.

Conclusions:

• Treatment decisions in MS require balancing efficacy, safety, and patient preferences.
• The traditional escalating therapy approach may not be optimal for all RMS patients.
• Personalized therapeutic strategies, potentially including early high-efficacy DMTs, are crucial for improving long-term MS outcomes.